World News: 12:05 GMT Monday 11th February 2019. [Myriad Genetics, Inc. via Globe Newswire via SPi World News]
SALT LAKE CITY, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that its Myriad Women’s Health subsidiary has enhanced the to include all 23 chromosome pairs rather than just the standard five chromosomes (13, 18, 21, X and Y) previously tested. Aneuploidies refer to extra or missing chromosomes that can lead to poor reproductive health outcomes. The expanded Prequel screen will be available to clinicians and patients starting Feb. 19, 2019.
“The goal of noninvasive prenatal screening (NIPS) is to provide women with information about the health of the pregnancy,” said James Goldberg, M.D., board certified medical geneticist and chief medical officer, Myriad Women’s Health. “Our expanded Prequel Prenatal Screen now provides patients with a comprehensive assessment of all 23 chromosome pairs for aneuploidies, which improves the detection of aneuploidies by about 30 percent, expanding the clinical utility of the screen.”
Prequel Prenatal Screen with expanded aneuploidy analysis can potentially improve birth outcomes by identifying more pregnancies at risk for birth defects and syndromes, as well as those at risk for pregnancy complications due to these chromosome changes in the placenta. This improves the opportunity for better monitoring, specialized ultrasounds and targeted prenatal diagnosis.
“Every woman who wants to know more about her pregnancy should be offered the Prequel Prenatal Screen,” said Goldberg. “In addition to testing all 23 chromosome pairs, Prequel has an industry-leading low test failure rate of 0.1 percent, which means patients receive reliable results the first time without the need for retesting.”
Globe Newswire: 12:05 GMT Monday 11th February 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.